0074-0034 : Zinbryta 150 mg/ml Subcutaneous Injection, Solution

Labeler: Abbvie
Product Type: Human Prescription Drug
Drug Name:  Zinbryta Pen
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA761029
Rev. Date: 

NDC Package Codes:

  • 0074-0034-01: 1 SYRINGE, GLASS IN 1 BOX (0074‑0034‑01) > 1 ML IN 1 SYRINGE, GLASS

Active Ingredients:

  • Daclizumab

Dosage Strength:

  • 150 mg/mL

Pharmaceutical Classes:

  • Interleukin 2 Receptor Antagonists [MoA]
  • Interleukin 2 Receptor-directed Antibody Interactions [MoA]
  • Interleukin-2 Receptor Blocking Antibody [EPC]


Scan the QR code below to easily reference this data in the future:

NDC 0074-0034 QR Code

< Prev: 0074-0033Next: 0074-0038 >

Related Discussions:

Zinbryta (daclizumab)
My husband spent seven weeks in the hospital, seriously ill. A major contributing factor is believed to be the Zinbryta ... 2 replies

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 July 2017.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA